Last update:

Alzheimer's disease & dementia news

Medical research

Dietary compound increases longevity and protects against Alzheimer's disease in experimental models

Researchers from the Color and Food Quality group at the Faculty of Pharmacy (University of Seville), in collaboration with Dr. Marina Ezcurra's group at the University of Kent (U.K.), have shown that the carotenoid phytoene ...

Alzheimer's disease & dementia

Questions over safety and effectiveness of new Alzheimer's drug

The safety and effectiveness of donanemab—an Alzheimer's drug recently approved by the US Food & Drug Administration (FDA)—is called into question in an investigation published by The BMJ.

Genetics

Master copper regulator discovery may offer Alzheimer's clues

New therapeutic opportunities often emerge from research on simple organisms. For instance, the 2020 Nobel Prize in Chemistry awarded to Emmanuelle Charpentier, Ph.D., and Jennifer Doudna, Ph.D., for their CRISPR-based DNA ...

Alzheimer's disease & dementia

Boosting brain protein levels may slow decline from Alzheimer's

A study published in the journal Brain shows that increases in protein levels with new Alzheimer's drugs can explain the slowing of cognitive impairment at least as well as the reduction in amyloid plaques.

Alzheimer's disease & dementia

Active social lives can help dementia patients, caregivers thrive

People with dementia and those who care for them should be screened for loneliness, so providers can find ways to keep them socially connected, according to experts at UC San Francisco and Harvard, who made the recommendations ...

Neuroscience

Decoding sleep to reveal our state of health

Sleep takes up almost one third of our life, yet many of its secrets remain unexplained. To penetrate the mystery, neuroscientists are trying to decipher some of the mechanisms of this basic biological function, so key to ...

Medications

FDA delays decision on new Alzheimer's drug

Instead of approving the new Alzheimer's drug donanemab this month, as was expected, the U.S. Food and Drug Administration will now require the experimental medication be scrutinized more closely by an expert panel, the drug's ...

Alzheimer's disease & dementia

Highly awaited Alzheimer's drug hit by delays

Eli Lilly's highly anticipated Alzheimer's drug has been held back for further review by regulators, the US pharmaceutical giant said Friday, in a blow for patients with the devastating brain disorder.

Alzheimer's disease & dementia

Do you really want to find out if you'll get Alzheimer's?

A few years ago, researchers made the unnerving discovery that in the brains of people with Alzheimer's disease, disordered clumps of abnormal proteins had been growing for 15 or even 20 years before their diagnosis. That ...

Neuroscience

People with essential tremor may have increased risk of dementia

Dementia may be three times more common among people with essential tremor, a movement disorder that causes involuntary shaking, than the general population, according to research released today, March 6, 2024. The study ...

Alzheimer's disease & dementia

Social determinants of health increase Alzheimer's risk

Social determinants of health are increasing the risk of Alzheimer's disease and related dementia, finds a recent study from the Brown School and the School of Medicine at Washington University in St. Louis.

Alzheimer's disease & dementia

Understanding lucid episodes in dementia

A recent Mayo Clinic study published in Alzheimer's & Dementia investigated lucid episodes in people living with later stages of dementia, providing insights into how these occurrences reveal themselves.